As per MRFR analysis, the India Poultry Vaccines Market Size was estimated at 270 (USD Million) in 2024. The India Poultry Vaccines Market Industry is expected to grow from 500 (USD Million) in 2025 to 850 (USD Million) by 2035. The India Poultry Vaccines Market CAGR (growth rate) is expected to be around 4.942% during the forecast period (2025 - 2035).
The India Poultry Vaccines Market is witnessing significant developments driven by various market drivers and trends. The rising demand for poultry products, propelled by increasing population and changing dietary habits, is a major force prompting farmers to prioritize poultry health through vaccination.
The Indian government is also focusing on biosecurity measures, aiding the adoption of essential vaccinations to prevent outbreaks of diseases such as avian influenza and Newcastle disease. Moreover, there is a growing awareness among poultry farmers about the importance of preventive healthcare, leading to an increased uptake of vaccines across the country.
Opportunities in the India Poultry Vaccines Market are abundant, particularly in expanding the reach of affordable vaccines to rural farmers. With approximately 70% of India's poultry production occurring in rural areas, effective distribution channels and education on vaccine benefits can enhance overall poultry health and productivity.
Additionally, the development of new and more effective vaccines tailored to regional diseases presents a chance for innovation and growth within the market. Recent trends also indicate a rise in collaborations between private vaccine manufacturers and government bodies to strengthen vaccination programs, ensuring better accessibility and affordability.
The shift towards more sustainable animal husbandry practices is further influencing the market, with a focus on reducing antibiotic usage in favor of vaccination. As India increasingly prioritizes food security and the health of its poultry sector, the focus on vaccine development and distribution is set to intensify, aligning with global best practices in animal health management. These factors collectively underscore the evolving landscape of the poultry vaccines market in India and its potential for future growth.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rising population in India, projected to surpass 1.4 billion by 2025, is driving the demand for poultry products, thereby increasing the need for effective poultry vaccines in the India Poultry Vaccines Market Industry. As per the National Agricultural Cooperative Marketing Federation of India, the poultry industry contributes approximately 25 percent to the country's agricultural gross domestic product, indicating significant market potential.
Established organizations like the Indian Poultry Equipment Manufacturers Association are focusing on promoting poultry farming, further fueling the need for vaccination to ensure healthy and productive flocks. With an increase in demand for safe and disease-free poultry products, the India Poultry Vaccines Market is expected to grow in alignment with this trajectory.
The Government of India has launched several initiatives to boost the poultry sector, including programs aimed at disease control and prevention. The National Livestock Mission aims to enhance production and productivity in the sector, ensuring farmers benefit from modern veterinary practices, including vaccination. Such initiatives highlight the importance of vaccination in improving livestock health.
The Indian government has allocated significant funds for Research and Development in veterinary sciences as part of its commitment to the poultry vaccine supply chain. The supportive policy environment will also aid the growth of the India Poultry Vaccines Market Industry, which is expected to expand tremendously with increased attention on biosecurity and poultry disease management.
There has been a growing awareness among poultry farmers about the importance of vaccination in maintaining flock health and productivity. According to a survey conducted by the Animal Husbandry department, over 60 percent of poultry farmers now understand the critical role of vaccines in preventing diseases like Newcastle disease and Infectious Bursal Disease.
Additionally, organizations such as the Indian Veterinary Association are actively involved in educating farmers about disease prevention strategies. The increased awareness is driving the demand for poultry vaccines and consequently expanding the India Poultry Vaccines Market Industry as farmers recognize the correlation between vaccinated flocks and higher economic returns.
The veterinary vaccination landscape is evolving with advancements in vaccine technology, including the development of recombinant vaccines and live attenuated vaccines that are more effective and safer for poultry. The Indian Council of Agricultural Research is actively promoting research in innovative vaccine formulations.
These advancements are reducing the incidence of poultry diseases and improving overall flock health. With the introduction of improved and efficient vaccines, the commercial poultry sector is likely to experience fewer outbreaks of disease. Consequently, this enhances the return on investment for poultry farmers, thus contributing positively to the growth of the India Poultry Vaccines Market Industry.
The India Poultry Vaccines Market showcases diverse types, each playing a crucial role in maintaining poultry health and productivity. The market emphasizes Live Attenuated Vaccines, which are significant due to their ability to stimulate a strong immune response while providing long-term protection against various diseases. Their effectiveness in combating infections in poultry populations makes them popular among poultry farmers across India.
Inactivated Vaccines also hold a substantial share of the market; these vaccines are essential for their safety profile, offering a reliable option for preventing disease without causing the disease itself, thereby protecting poultry health effectively. Additionally, Subunit Vaccines have gained importance in recent years, especially as they present a focused approach by targeting specific components of pathogens.
This specificity results in a reduced risk of adverse reactions and enhances the safety of vaccinated birds. Furthermore, the incorporation of DNA Vaccines is emerging as a transformative approach, primarily due to their ability to provide a strong immune response and their potential for long-lasting protection. This innovative type of vaccine is particularly relevant in a region like India, where poultry farming is a significant contributor to the livelihoods of many farmers.
The growth of the India Poultry Vaccines Market is driven by the increasing demand for poultry products, necessitating the need for effective vaccination programs to prevent outbreaks of diseases. With the rise in awareness among farmers about disease management and biosecurity measures, there is a growing inclination towards advanced vaccination techniques.
The government initiatives aimed at promoting poultry health and biosecurity, along with investments in Research and Development, further bolster the market. However, challenges such as the need for cold-chain supply management and regional variations in poultry health requirements may impact the accessibility and adoption of certain vaccine types. Overall, the Type segmentation within the India Poultry Vaccines Market continues to evolve, offering opportunities for innovation and expansion in response to the growing needs of the industry.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Species segment of the India Poultry Vaccines Market represents a crucial part of the industry, significantly contributing to overall growth and consumer health. Broilers have emerged as a dominant force in this segment due to the high demand for meat production in India, where poultry is a primary protein source for many households.
Layers also play a vital role, given the increasing focus on egg production and the growing awareness among consumers about the nutritional benefits of eggs. Turkeys are gaining traction as consumers become more adventurous with their meat choices, providing opportunities for specialized vaccines to support this segment.
The 'Others' category encompasses various poultry types that, while smaller in volume, cater to niche markets and specialty demands. As the demand for poultry products continues to rise, driven by urbanization and changing dietary habits, the importance of effective vaccination strategies in these segments cannot be overstated.
The India Poultry Vaccines Market revenue is expected to find support in these diverse species categories, reflecting an evolving landscape that prioritizes health, growth performance, and biosecurity in poultry farming practices. Market trends indicate that vaccine innovation and Research and Development will significantly influence the future trajectory of these segments, addressing challenges such as disease outbreaks and antibiotic use.
The Administration Route segment of the India Poultry Vaccines Market plays a crucial role in determining the effectiveness and uptake of vaccines. This segment includes various methods such as Intramuscular, Subcutaneous, Oral, and Inhalation, each offering distinct advantages and applications.
Intramuscular vaccination is recognized for its rapid immune response, which is critical in preventing diseases within poultry populations. Subcutaneous methods are often employed for their ease of administration, allowing for efficient mass vaccinations. Oral vaccines are gaining traction due to their user-friendliness and the ability to immunize large groups quickly through feed or water.
Inhalation techniques represent a more novel approach, targeting respiratory diseases prevalent in poultry, particularly in densely populated farming operations. With the Indian government promoting biosecurity measures and vaccination programs to enhance poultry health, the demand for diverse administration routes in vaccines is likely to rise.
This increase not only supports overall poultry production but also contributes to the improvement of the country's food security. Understanding the dynamics of these administration methods is essential, as they represent significant choices for poultry farmers in safeguarding their flocks against common diseases.
The Disease Targeted segment of the India Poultry Vaccines Market is crucial for ensuring the health and productivity of poultry. Newcastle Disease is one of the foremost concerns, notorious for its rapid spread and high mortality rates, thereby necessitating effective vaccination strategies to protect flocks.
Infectious Bursal Disease also poses significant risks, particularly to young birds, and timely vaccination can prevent large-scale economic losses for farmers. On the other hand, Avian Influenza remains a critical threat not just for poultry but also poses zoonotic risks to humans, making robust vaccination programs vital for public health.
Marek's Disease, while less widespread than the other diseases, still affects immune function, leading to substantial losses in egg production and weight gain in birds. Overall, the importance of these diseases highlights the need for advanced vaccines in India’s poultry industry, as they play a pivotal role in maintaining biosecurity and enhancing market growth. As consumer demand for poultry products increases, the focus on targeted vaccinations is expected to intensify, promoting sustainable farming practices and boosting overall production efficiency in the country.
The India Poultry Vaccines Market is characterized by a rapidly evolving landscape driven by increasing demand for poultry products and a growing awareness of animal health and welfare. The market is heavily influenced by various factors including government regulations, advancements in veterinary medicine, and the rising incidences of poultry diseases. Companies are constantly innovating and adapting their strategies to enhance production capabilities and expand their portfolios in response to significant competition.
This market is marked by numerous global and regional players who are striving to capture market share through diversified product offerings and strong distribution networks. The competitive dynamics of this sector are further complicated by strategies focused on mergers and acquisitions, collaborations, and partnerships, which are pivotal for scaling operations and enhancing technological capabilities.
Hipra is a notable player in the India Poultry Vaccines Market, recognized for its innovative and research-driven approach to vaccine development. The company has established a strong presence in the Indian poultry industry, focusing on delivering high-quality vaccines that address the unique challenges faced by poultry farmers in the region. Hipra’s strengths lie in its robust research and development capabilities, which have allowed it to introduce cutting-edge vaccine solutions tailored to both viral and bacterial infections in poultry.
The company’s commitment to quality and efficacy, along with a strategic emphasis on customer education and support, has positioned Hipra favorably within a competitive framework. The combination of its comprehensive product portfolio and emphasis on preventive health in poultry contributes significantly to its reputation as a trusted partner among poultry producers across India.
Indian Immunologicals has made a significant mark in the India Poultry Vaccines Market, primarily known for its extensive range of vaccine products specifically designed for poultry health. The company's key offerings include vaccines that address critical diseases, enhancing the immunity and overall health of poultry stocks. Through strategic investments and a focus on research and innovation, Indian Immunologicals has managed to strengthen its market presence, ensuring competitive positioning against both local and international players.
Moreover, the company’s strengths are evident in its ability to adapt to market needs through continuous product development and maintaining stringent quality control measures. Furthermore, Indian Immunologicals has engaged in various mergers and acquisitions that have bolstered its operational capabilities and expanded its product offerings, thereby enhancing its footprint in the Indian poultry vaccines market while reinforcing its commitment to improving animal health standards across the region.
The India Poultry Vaccines Market has seen significant developments recently, particularly in the launch of innovative vaccines and expansions by key players. Notably, in September 2023, Hester Biosciences introduced a new vaccine against a prevalent avian disease, improving the health of poultry and meeting rising demand in the region.
Indian Immunologicals has also been active, announcing plans to increase its production capacity for poultry vaccines to cater to the growing market. In terms of mergers and acquisitions, in August 2023, Boehringer Ingelheim announced its acquisition of a local vaccine development firm, strengthening its position in the Indian market.
The market is experiencing healthy growth, driven by rising poultry consumption and increasing awareness of animal health, with estimates projecting a compound annual growth rate of over 10% from 2022 to 2027. Additionally, the ongoing impact of the government's initiatives to enhance biosecurity measures in poultry farming is expected to create new opportunities for vaccine manufacturers. The collective efforts of these companies including Zoetis, Ceva Santé Animale, Merck Animal Health, and others contribute to a dynamic landscape, shaping the future of poultry health in India.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 270.0(USD Million) |
| MARKET SIZE 2024 | 500.0(USD Million) |
| MARKET SIZE 2035 | 850.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.942% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Hipra, Indian Immunologicals, Venkateshwara Hatcheries, Sysmex, Ceva Santé Animale, Piramal Healthcare, Zoetis, Vetoquinol, Hester Biosciences, Biovet, Zydus Cadila, Merck Animal Health, MSD Animal Health, Thermo Fisher Scientific, Boehringer Ingelheim |
| SEGMENTS COVERED | Type, Species, Administration Route, Disease Targeted |
| KEY MARKET OPPORTUNITIES | Rising poultry farming trends, Increased disease outbreaks, Adoption of advanced vaccine technology, Growing awareness of animal health, Government support and subsidies |
| KEY MARKET DYNAMICS | growing poultry population, increasing disease outbreaks, rising awareness of vaccination, government support and regulations, advancements in vaccine technology |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Poultry Vaccines Market is expected to be valued at 500.0 USD Million in 2024.
By 2035, the India Poultry Vaccines Market is anticipated to reach a value of 850.0 USD Million.
The CAGR for the India Poultry Vaccines Market is forecasted to be 4.942 percent during the period from 2025 to 2035.
Live Attenuated Vaccines are expected to dominate the market, valued at 200.0 USD Million in 2024.
In 2024, the Inactivated Vaccines segment is projected to be valued at 150.0 USD Million.
Major players in the market include Hipra, Indian Immunologicals, and Venkateshwara Hatcheries among others.
The projected value for Subunit Vaccines in 2035 is expected to reach 140.0 USD Million.
There are significant growth opportunities driven by increasing poultry farming and vaccination awareness.
DNA Vaccines are expected to grow from a value of 60.0 USD Million in 2024 to 115.0 USD Million by 2035.
Challenges include stringent regulations and the increasing cost of vaccine development impacting market growth.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
